期刊
DRUG DISCOVERY TODAY
卷 23, 期 5, 页码 1034-1042出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2017.11.006
关键词
-
资金
- Danish Agency for Science, Technology and Innovation (Det Strategiske Forskningsrad) [09-065746]
- Danish Council for Independent Research, Technology and Production Sciences [12-126894, 1335-00150b]
- Lundbeckfonden [R100-A9443]
- International Science and Technology Cooperation of Guangdong Province [2015A050502002]
- Guangzhou City [2016201604030050]
- RiboBio Co, Ltd, China
Injection/infusion reactions to nanopharmaceuticals (and particulate drug carriers) are idiosyncratic and well documented. The molecular basis of nanoparticle-mediated injection reactions is debatable, with two hypotheses as front-runners. The first is complement-activation-related 'pseudoallergy', where a causal role for nanoparticle-mediated complement activation in injection/infusion reactions is considered. However, the second hypothesis (the rapid phagocytic response hypothesis) states a transitional link from robust clearance of nanoparticles (NPs) from the blood by strategically placed responsive macrophages to adverse hemodynamic and cardiopulmonary reactions, regardless of complement activation. Here, I critically examine and discuss these hypotheses. Current experimentally derived evidence appears to be more in support of the rapid phagocytic response hypothesis than of the 'pseudoallergy' hypothesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据